Showing 1 - 4 results of 4 for search 'Mikhail Kosiborod', query time: 0.03s Refine Results
  1. 1
    Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme

    Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme by Peter Fenici, Niklas Hammar, Linong Ji, Fengming Tang, Hirotaka Watada, Antonio Nicolucci, Wolfgang Rathmann, Iichiro Shimomura, Marilia B Gomes, Mikhail Kosiborod, Stuart Pocock, Marina V Shestakova, Hungta Chen, Javier Cid-Ruzafa

    Published 2020-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study

    Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study by Jesús Medina, Peter Fenici, Linong Ji, Fengming Tang, Hirotaka Watada, Antonio Nicolucci, Wolfgang Rathmann, Suzanne V Arnold, Iichiro Shimomura, Mikhail Kosiborod, Hungta Chen, Andrew Cooper, Brenda Bongaerts, Bernard H Charbonnel, Marilia Gomes, Marina Shestakova

    Published 2021-03-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Chronic kidney disease prevalence and outcomes in patients with type 2 diabetes or prediabetes at high cardiovascular risk: results from the CINEMA program

    Chronic kidney disease prevalence and outcomes in patients with type 2 diabetes or prediabetes at high cardiovascular risk: results from the CINEMA program by Sanjana Datla, Zainab Albar, Elke Eaton, Jodie Porges, Matthew Nennstiel, Claire Sullivan, Lloyd Greene, Sadeer G. Al-Kindi, Elizabeth Montgomery, Aparna Padiyar, Mikhail Kosiborod, Melissa L. Magwire, Mahboob Rahman, Sanjay Rajagopalan, Ian J. Neeland

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes

    CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes by Oliver Schnell, Jaime Almandoz, Lisa Anderson, Katharine Barnard-Kelly, Tadej Battelino, Matthias Blüher, Luca Busetto, Doina Catrinou, Antonio Ceriello, Xavier Cos, Thomas Danne, Colin M. Dayan, Stefano Del Prato, Beatriz Fernández-Fernández, Paola Fioretto, Thomas Forst, James R. Gavin, Francesco Giorgino, Per-Henrik Groop, Igor A. Harsch, Hiddo J. L. Heerspink, Lutz Heinemann, Mahmoud Ibrahim, Michel Jadoul, Sarah Jarvis, Linong Ji, Naresh Kanumilli, Mikhail Kosiborod, Ulf Landmesser, Sofia Macieira, Boris Mankovsky, Nikolaus Marx, Chantal Mathieu, Barbara McGowan, Tatjana Milenkovic, Othmar Moser, Dirk Müller-Wieland, Nikolaos Papanas, Dipesh C. Patel, Andreas F. H. Pfeiffer, Dario Rahelić, Helena W. Rodbard, Lars Rydén, Elke Schaeffner, C. Wendy Spearman, Alin Stirban, Frank Tacke, Pinar Topsever, Luc Van Gaal, Eberhard Standl

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: